Effects of long-term androgen administration on breast tissue of female-to-male transsexuals

Journal of Histochemistry and Cytochemistry

Volumn 54, Issue 8, 2006, Pages 905-910

  Slagter, Margrita H ^a   Gooren, Louis J G ^a   Scorilas, Andreas ^b   Petraki, Constantina D ^c   Diamandis, Eleftherios P ^d,e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ATHENS   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast tissue; Hormones; Immunohistochemistry; Transsexuals

Indexed keywords

ANDROGEN; EOSIN; HEMATOXYLIN; KALLIKREIN; TESTOSTERONE;

ANDROGEN THERAPY; ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FEMALE TO MALE TRANSSEXUAL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; MALE; MYOEPITHELIUM CELL; PRIORITY JOURNAL; TISSUE FIXATION; TRANSSEXUALISM; VIRILIZATION;

ANDROGENS; BREAST; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; PROSTATE-SPECIFIC ANTIGEN; TESTOSTERONE; TRANSSEXUALISM;

EID: 33746299211     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.6A6928.2006     Document Type: Article

References (35)

1. Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR (1997) Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 79:494-499
2. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, et al. (2002) Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77:660-665
3. Balen A (2001) Polycystic ovary syndrome and cancer. Hum Reprod Update 7:522-525
4. Black MH, Diamandis EP (2000) The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast. Breast Cancer Res Treat 59:1-14
5. Borgono CA, Diamandis EP (2004) The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4:876-890
6. Borgono CA, Michael IP, Diamandis EP (2004) Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2:257-280
7. Burgess HE, Shousha S (1993) An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia. J Pathol 170:37-43
8. Clements JA, Willemsen NM, Myers SA, Dong Y (2004) The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit Rev Clin Lab Sci 41:265-312
9. Davison SL, Davis SR (2003) Androgens in women. J Steroid Biochem Mol Biol 85:363-366
10. Dhar S, Bhargava R, Yunes M, Li B, Goyal J, Naber SP, Wazer DE, et al. (2001) Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin Cancer Res 7:3393-3398
11. Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV (2000) The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol Metab 11:54-60
12. Futterweit W, Schwartz IS (1988) Histopathology of the breasts of 12 women receiving long-term exogenous androgen therapy. Mt Sinai J Med 55:309-312
13. Goh VH (1999) Breast tissues in transsexual women-a nonprostatic source of androgen up-regulated production of prostate-specific antigen. J Clin Endocrinol Metab 84:3313-3315
14. Goyal J, Smith KM, Cowan JM, Wazer DE, Lee SW, Band V (1998) The role for NES1 serine protease as a novel tumor suppressor. Cancer Res 58:4782-4786
15. Howarth DJ, Aronson IB, Diamandis EP (1997) Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues. Br J Cancer 75:1646-1651
16. Kandouz M, Lombet A, Perrot JY, Jacob D, Carvajal S, Kazem A, Rostene W, et al. (1999) Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol 69:463-471
17. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616
18. Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin SX, Pelletier G (2003) Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 24:152-182
19. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856-1865
20. Obiezu CV, Giltay EJ, Magklara A, Scorilas A, Gooren LJ, Yu H, Howarth DJ, et al. (2000) Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. Clin Chem 46:859-862
21. Petraki CD, Karavana VN, Diamandis EP (2003) Human kallikrein 13 expression in normal tissues: an immunohistochemical study. J Histochem Cytochem 51:493-501
22. Petraki CD, Karavana VN, Luo LY, Diamandis EP (2002) Human kallikrein 10 expression in normal tissues by immunohistochemistry. J Histochem Cytochem 50:1247-1261
23. Petraki CD, Karavana VN, Skoufogiannis PT, Little SP, Howarth DJ, Yousef GM, Diamandis EP (2001) The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues as assessed by immunohistochemistry. J Histochem Cytochem 49:1431-1441
24. Rivera-Woll LM, Papalia M, Davis SR, Burger HG (2004) Androgen insufficiency in women: diagnostic and therapeutic implications. Hum Reprod Update 10:421-432
25. Rochefort H, Garcia M (1983) The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther 23:193-216
26. Sapino A, Pietribiasi F, Godano A, Bussolati G (1990) Effect of long-term administration of androgens on breast tissues of female-to-male transsexuals. Ann N Y Acad Sci 586:143-145
27. Solomon CG (1999) The epidemiology of polycystic ovary syndrome: prevalence and associated disease risks. Endocrinol Metab Clin North Am 28:247-263
28. Somboonporn W, Davis SR (2004a) Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25:374-388
29. Somboonporn W, Davis SR (2004b) Postmenopausal testosterone therapy and breast cancer risk. Maturitas 49:267-275
30. Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG, Gooren LJ (1989) The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab 69:151-157
31. Wild S, Pierpoint T, Jacobs H, McKeigue P (2000) Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil 3:101-105
32. Yousef GM, Chang A, Diamandis EP (2000) Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues. J Biol Chem 275:11891-11898
33. Yousef GM, Diamandis EP (2001) The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 22:184-204
34. Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, et al. (2002) Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin Chem 48:1241-1250
35. Zhou J, Ng S, Sanya-Famuiya O, Anderson K, Bondy CA (2000) Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 14:1725-1730